Tomilina N Iu, Shipulina N V, Kovalev I E
Farmakol Toksikol. 1988 Sep-Oct;51(5):75-8.
There was studied the possibility of covalent binding to proteins of a carcinogenic compound benzo(a)pyrene in the system of cytochrome P-450 of the liver and the possibility of the development of the immune reaction to administration of the conjugated antigens obtained in such a way to animals. It was shown that under experimental conditions modelling the processes of microsomal oxidation of benzo(a)pyrene in the organism there occurs irreversible binding of 14C-benzo(a)pyrene both to microsomes and the added albumin. Immunization of rabbits by conjugates benzo(a)pyrene-albumin and benzo(a)pyrene-microsomes leads to the development of the immune response to the original carcinogen. The antibodies and lymphocytes specifically binding 14C-benzo(a)pyrene appear in the blood.
研究了在肝脏细胞色素P - 450系统中致癌化合物苯并(a)芘与蛋白质共价结合的可能性,以及将以此方式获得的共轭抗原给予动物后发生免疫反应的可能性。结果表明,在模拟机体中苯并(a)芘微粒体氧化过程的实验条件下,14C - 苯并(a)芘与微粒体和添加的白蛋白均发生不可逆结合。用苯并(a)芘 - 白蛋白和苯并(a)芘 - 微粒体共轭物免疫兔子会导致对原始致癌物产生免疫反应。血液中出现特异性结合14C - 苯并(a)芘的抗体和淋巴细胞。